Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.022 AUD | 0.00% | -18.52% | -37.14% |
05-16 | Chimeric Therapeutics Reopens Enrollment in Phase 1B Cell Therapy Study | MT |
05-02 | Chimeric Therapeutics Appoints COO; Shares Rise 4% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-37.14% | 13.16M | |
+8.29% | 113B | |
+10.21% | 106B | |
+0.41% | 22.27B | |
-11.90% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.17% | 17.24B | |
+7.70% | 14.29B | |
+37.65% | 12.52B |
- Stock Market
- Equities
- CHM Stock
- News Chimeric Therapeutics Limited
- Chimeric Therapeutics Treats First Patient in Phase 1B Leukemia Trial